South Korea: AstraZaneca gets approval for all aged 18-plus
January 21, 2022
Asia

South Korea: AstraZeneca gets approval for all aged 18-plus

SEOUL (SOUTH KOREA) – South Korea’s drug safety ministry on Wednesday has approved the use of AstraZeneca PLC’s COVID-19 vaccine for everyone, including those aged 65 and above.

The AstraZeneca shot, co-developed by Britain’s Oxford University, is the first vaccine to be granted approval in the country.

Related Posts